ArticleFrontiers in microbiology2023
Phylogenomics of
Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 23 citations in OpenAlex.
- In silico metabolic profiling of non-baumannii Acinetobacter species uncovers conserved functions and provides first evidence of siderophore biosynthetic genes in Acinetobacter junii.Scientific reports · 2026Article
- Antibiotic Resistance ofAnimals : an open access journal from MDPI · 2026Article
- Variations in plasmid transfer inMicrobiology spectrum · 2026Article
- Phenotypic and genotypic characterization ofOne health (Amsterdam, Netherlands) · 2026Article
- Article
- Article
- Genomic analysis of carbapenem-resistant non-Frontiers in microbiology · 2026Article
- Deciphering the genomic landscape of novelFrontiers in microbiology · 2026Article
- Distinct codon usage signatures reflecting evolutionary and pathogenic adaptation in the Acinetobacter baumannii complex.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Article
- Carbapenem-ResistantMicroorganisms · 2025Review
- Article
- Carbapenem Resistance inMicroorganisms · 2025Review
- β-Lactamase diversity inAntimicrobial agents and chemotherapy · 2025Article
- Whole-genome sequencing ofMicrobial genomics · 2025Article
- Pathogenicity and virulence ofVirulence · 2024Review
- Detection of florfenicol resistance in opportunisticFrontiers in microbiology · 2024Article
- Cefiderocol and Sulbactam-Durlobactam against Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Non- Methods: Phylogenies were performed on Pasteur Multilocus Sequence Typing (MLST) or ribosomal Multilocus Sequence Typing (rMLST) concatenated alleles, or SNPs extracted from core genome alignment. Results: The Pasteur MLST scheme was able to identify and genotype 72 species in the Conclusion: In conclusion, Pasteur MLST phylogeny of non-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.